Altshuler Shaham LTD Catalyst Pharmaceuticals, Inc. Transaction History

Altshuler Shaham LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	SELL	$14.34 - $21.05 $51,724 - $75,927	-3,607 Closed	0 $0
Q4 2022 May 09, 2023	SELL	$12.25 - $19.5 $5,402 - $8,599	-441 Reduced 10.89%	3,607 $67,000
Q3 2022 Nov 14, 2022	SELL	$7.06 - $15.52 $38,547 - $84,739	-5,460 Reduced 57.43%	4,048 $51,000
Q2 2022 Aug 10, 2022	BUY	$6.23 - $8.57 $28,302 - $38,933	4,543 Added 91.5%	9,508 $67,000
Q1 2022 May 16, 2022	SELL	$5.31 - $8.31 $9,542 - $14,933	-1,797 Reduced 26.57%	4,965 $41,000

Q4 2021 Feb 15, 2022	SELL	$5.21 - $7.45 $14,582 - $20,852	-2,799 Reduced 29.28%	6,762 $46,000
Q3 2021 Nov 15, 2021	SELL	$4.85 - $6.04 $46,070 - $57,373	-9,499 Reduced 49.84%	9,561 $51,000
Q2 2021 Aug 16, 2021	BUY	$4.29 - $6.05 $81,767 - $115,313	19,060 New	19,060 $110,000

277

95.7M

40.6K

67.2K

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $1.59B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

Get notified when there are updates to the investment portfolio of Altshuler Shaham LTD, based on Form 13F filings with the SEC.

Stay updated on Altshuler Shaham LTD with notifications on news.